KMCRIC

The Neuro4D is an international conference on Neuro Degenerative Disease Drug Discovery bringing together drug discovery companies, service and technology providers and academic innovators in the field of proteopathic neurodegenerative diseases such as Alzheimer’s dementia and Parkinson’s disease, etc. 

This second event will have a spotlight on Parkinson’s disease, where much progress in understanding disease onset, disease progression in the brain and the underlying and accompanying molecular changes, has been made. AD and other indications involving prion-like disease induction and progression will be covered as well. Misfolded and toxic protein aggregates replicating by templating correctly folded monomer proteins, are the common denominator of all these diseases, a view supported by the majority of international experts now. Presentations will cover elucidating the molecular events that result in synaptic loss and neuronal death, as well as neuro-inflammation, which is another common hallmark of neurodegeneration.

The conference differentiates itself by bringing together distinguished industry and academic speakers to update attendees about the state of the art in neurodegenerative disease drug discovery. Biotech and international pharmaceutical drug discovery companies will present their most recent achievements to develop new treatment options and outline the models and technologies used in compound selection and optimization. Service and technology companies will present their platforms and show examples of how their services contribute to the discovery of new drug candidates.